Mechanisms of measles virus oncolytic immunotherapy.

Pidelaserra-Martí, Gemma; Engeland, Christine E

Pidelaserra-Martí, Gemma; Engeland, Christine E.

Afiliação

Pidelaserra-Martí G; Research Group Mechanisms of Oncolytic Immunotherapy, Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; Faculty of Biosciences, Heidelberg University and Helmholtz International Graduate School for Cancer Research, DKFZ, Heidelberg, Germany. Electronic address: gemma.pidelaserramarti@nct-heidelberg.de.
Engeland CE; Research Group Mechanisms of Oncolytic Immunotherapy, Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; University Hospital Heidelberg, Department of Medical Oncology, Heidelberg, Germany; Faculty of Health/School of Medicine, Institute of Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, Germany. Electronic address: christine.engeland@nct-heidelb

Cytokine Growth Factor Rev ; 56: 28-38, 2020 12.

Article em En | MEDLINE | ID: mdl-32660751

Assuntos

Imunoterapia; Vírus do Sarampo; Terapia Viral Oncolítica; Vírus Oncolíticos; Humanos; Vacina contra Sarampo

Palavras-chave

Cancer immunity cycle; Cancer immunotherapy; Immunogenic cell death; Measles virus; Oncolytic virotherapy; Tumor vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica / Imunoterapia / Vírus do Sarampo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cytokine Growth Factor Rev Assunto da revista: ALERGIA E IMUNOLOGIA / BIOQUIMICA Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google